News

Sophisticated programs require an evolving mindset.

Clinician-scientists play a vital role in advancing ophthalmology by balancing patient care with research, leveraging clinical insights to drive impactful discoveries, and collaborating across disciplines to stay at the forefront of innovation.

PYK-2101 is a first-in-class biodegradable retinal hydrogel sealant.

The authors said their results provide strong support that cultivated autologous limbal epithelial cell transplantation is safe and feasible

One in vitro study included in the manuscript was conducted in collaboration with researchers at the University of Southhampton in the United Kingdom

At the Envision Summit 2025 in San Juan, Puerto Rico, Amy Zhang, MD, discussed the importance of ergonomics in the operating room.

The investigators' findings suggest that CVI is a valuable noninvasive predictive biomarker for monitoring vascular changes in patients who smoke

At the EnVision Summit 2025 in San Juan, Puerto Rico, Tania Tai, Lucy Shen, and Shivani Kamat all gave insight into complications they have seen while performing glaucoma surgery.

Apellis Pharmaceuticals and EyePoint Pharmaceuticals are both scheduled to present at the conference.

Zervimesine is an investigational oral, once-daily pill being developed for the treatment of CNS diseases, including Alzheimer disease and dementia with Lewy bodies.

These tools help fill a gap that current technologies cannot achieve as effectively.

The aim of the study was to assess the effect of a modified TCLB procedure that added deframing and decompression maneuvers to the LOFC and its support structures to obtain better results for both the lower and upper lids.

Researchers conducted a first-of-a-kind cross-sectional study at the outpatient clinic of the Eye Hospital of China Academy of Chinese Medical Sciences from March to June 2024

This follows successful Phase 1 results, which demonstrated a favorable safety profile for BI 771716 across both single and multiple intravitreal doses.

The research analyzed the 1-year outcomes of 132 eyes, evaluating mean IOP, baseline changes, medication reduction, and stratifying the results by race (African American vs Caucasian) and glaucoma severity (mild, moderate, severe).

The company also reported a positive outcome of an analysis of masked data from its ongoing MAGNIFY Phase 2 trial for zervimesine in adults with GA.

Toric IOLs outperform femtosecond laser-assisted astigmatic keratotomy in reducing postoperative astigmatism and improving UDVA after cataract surgery.

Meibomian glands are critical to the ocular health in that they secrete lipid-rich meibum, which protects the ocular surface by preventing tear film evaporation.

This device is designed to assist healthcare professionals in analyzing fundus images for the early detection of key retinal conditions.

What do ophthalmologists consider the key advancements in treating glaucoma over the last several decades?

The researchers reported a “notable” correlation which could serve as a predictive biomarker

Emerging technologies, such as remote tonometry and genetic risk scoring, are revolutionizing glaucoma care by enabling earlier detection, personalized management, and more efficient use of resources.

If approved, the drug will be branded as LYTENAVA.

We asked ophthalmologists what stands out to them in the history of treating glaucoma and where future treatments might be heading.

The procedure offers a renewed approach to suprachoroidal drainage, with potential for both combined and standalone glaucoma surgery.

In the group of new appointees, the organisation welcomed community members who are passionate about advocacy and education

Researchers indicated that pediatric patients with Leber congenital amaurosis experienced improvements in vision.